miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A |
Chen, Ling
(Department of Gastroenterology, the 324th Hospital of PLA)
Xiao, Hong (Department of Gastroenterology, the 324th Hospital of PLA) Wang, Zong-Hua (School of Nursing, Third Military Medical University) Huang, Yi (Department of Gastroenterology, the 324th Hospital of PLA) Liu, Zi-Peng (Department of Gastroenterology, the 324th Hospital of PLA) Ren, Hui (School of Nursing, Third Military Medical University) Song, Hang (Department of Gastroenterology, the 324th Hospital of PLA) |
1 | Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T. and Satoh, J. (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 36, 320-330. DOI ScienceOn |
2 | Ahluwalia, J. K., Khan, S. Z., Soni, K., Rawat, P., Gupta, A., Hariharan, M., Scaria, V., Lalwani, M., Pillai, B., Mitra, D. and Brahmachari, S. K. (2008) Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5, 117. DOI ScienceOn |
3 | Bandyopadhyay, S., Friedman, R. C., Marquez, R. T., Keck, K., Kong, B., Icardi, M. S., Brown, K. E., Burge, C. B., Schmidt, W. N., Wang, Y. and McCaffrey, A. P. (2011) Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J. Infect. Dis. 203, 1753-1762. DOI ScienceOn |
4 | Li, J., Zhang, Y., Kuruba, R., Gao, X., Gandhi, C. R., Xie, W. and Li, S. (2011) Roles of miR-29a in the antifibrotic effect of FXR in hepatic stellate cells. Mol. Pharmacol. 89, 191-200. |
5 | Mulkeen, A. L., Silva, T., Yoo, P. S., Schmitz, J. C., Uchio, E., Chu, E. and Cha, C. (2006) Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells. Arch. Surg. 141, 367-374. DOI ScienceOn |
6 | Petit, A. M., Rak, J., Hung, M. C., Rockwell, P., Goldstein, N., Fendly, B. and Kerbel, R. S. (1997) Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151, 1523-1530. |
7 | Des Guetz G, Uzzan, B., Nicolas, P., Cucherat, M., Morere, J. F., Benamouzig, R., Breau, J. L. and Perret, G. Y. (2006) Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br. J. Cancer 94, 1823-1832. DOI ScienceOn |
8 | Kolev, Y., Uetake, H., Iida, S., Ishikawa, T., Kawano, T. and Sugihara, K. (2007) Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann. Surg. Oncol. 14, 2738-2747. DOI |
9 | Ugalde, A. P., Ramsay, A. J., de la Rosa, J., Varela, I., Marino, G., Cadinanos, J., Lu, J., Freije, J. M. and Lopez-Otin, C. (2011) Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J. 30, 2219-2232. DOI ScienceOn |
10 | Cui, Y., Su, W. Y., Xing, J., Wang, Y. C., Wang, P., Chen, X. Y., Shen, Z. Y., Cao, H., Lu, Y. Y. and Fang, J. Y. (2011) MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 6, e25872. DOI |
11 | Ghosh, R., Lipson, K. L., Sargent, K. E., Mercurio, A. M., Hunt, J. S., Ron, D. and Urano, F. (2010) Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One 5, e9575. DOI ScienceOn |
12 | Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. DOI ScienceOn |
13 | Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S. and Gasparini, G. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875-1887. DOI |
14 | Wicha, M. S. (2011) Stemming a tumor with a little miR. Nat. Med. 17, 162-164. DOI ScienceOn |
15 | Tie, J., Pan, Y., Zhao, L., Wu, K., Liu, J., Sun, S., Guo, X., Wang, B., Gang, Y., Zhang, Y., Li, Q., Qiao, T., Zhao, Q., Nie, Y. and Fan, D. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 6, e1000879. DOI ScienceOn |
16 | Zhu, S., Si, M. L., Wu, H. and Mo, Y. Y. (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282, 14328-14336. DOI ScienceOn |
17 | Kloosterman, W. P. and Plasterk, R. H. (2006) The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441-450. DOI ScienceOn |
18 | Esquela-Kerscher, A. and Slack, F. J. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269. DOI ScienceOn |
19 | Lewis, B. P., Burge, C. B. and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20. DOI ScienceOn |
20 | Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. and Croce, C. M. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101, 2999-3004. DOI ScienceOn |
21 | Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S. and Mo, Y. Y. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18, 350-359. DOI ScienceOn |
22 | Hiyoshi, Y., Kamohara, H., Karashima, R., Sato, N., Imamura, Y., Nagai, Y., Yoshida, N., Toyama, E., Hayashi, N., Watanabe, M. and Baba, H. (2009) MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin. Cancer Res. 15, 1915-1922. DOI ScienceOn |
23 | Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., Dong, W., Huang, J. and Lin, T. (2011) MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int. J. Cancer 128, 1758-1769. DOI ScienceOn |
24 | Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. and Croce, C. M. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101, 2999-3004. DOI ScienceOn |
25 | Lo, W. L., Yu, C. C., Chiou, G. Y., Chen, Y. W., Huang, P. I., Chien, C. S., Tseng, L. M., Chu, P. Y., Lu, K. H., Chang, K. W., Kao, S. Y. and Chiou, S. H. (2011) MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J. Pathol. 223, 482-495. DOI ScienceOn |
26 | Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y. and Zheng, X. (2009) miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275, 44-53. DOI ScienceOn |
27 | Ward, B. P., Tsongalis, G. J. and Kaur, P. (2011) MicroRNAs in chronic lymphocytic leukemia. Exp. Mol. Pathol. 90, 173-178. DOI ScienceOn |
28 | Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P. and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105. DOI ScienceOn |
29 | Maragkakis, M., Alexiou, P., Papadopoulos, G. L., Reczko, M., Dalamagas, T., Giannopoulos, G., Goumas, G., Koukis, E., Kourtis, K., Simossis, V. A., Sethupathy, P., Vergoulis, T., Koziris, N., Sellis, T., Tsanakas, P. and Hatzigeorgiou, A. G. (2009) Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 10, 295. DOI ScienceOn |
30 | Maragkakis, M., Reczko, M., Simossis, V. A., Alexiou, P., Papadopoulos, G. L., Dalamagas, T., Giannopoulos, G., Goumas, G., Koukis, E., Kourtis, K., Vergoulis, T., Koziris, N., Sellis, T., Tsanakas, P. and Hatzigeorgiou, A. G. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 37, W273-276. DOI ScienceOn |
31 | Rehmsmeier, M., Steffen, P., Hochsmann, M. and Giegerich, R. (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10, 1507-1517. DOI ScienceOn |
32 | Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F. and Detmar, M. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089-1099. DOI ScienceOn |
33 | Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. and Calin, G. A. (2009) MicroRNAs--the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293-302. DOI ScienceOn |
34 | Pandey, A. K., Verma, G., Vig, S., Srivastava, S., Srivastava, A. K. and Datta, M. (2011) miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol. Cell. Endocrinol. 332, 125-133. DOI ScienceOn |
35 | Kawashita, Y., Jinnin, M., Makino, T., Kajihara, I., Makino, K., Honda, N., Masuguchi, S., Fukushima, S., Inoue, Y. and Ihn, H. (2011) Circulating miR-29a levels in patients with scleroderma spectrum disorder. J. Dermatol. Sci. 61, 67-69. DOI ScienceOn |
36 | Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A. and De Strooper B (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U. S .A. 105, 6415-6420. DOI ScienceOn |
37 | Du B, Ma, L. M., Huang, M. B., Zhou, H., Huang, H. L., Shao, P., Chen, Y. Q. and Qu, L. H. (2010) High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett. 584, 811-816. DOI ScienceOn |
38 | Desjobert, C., Renalier, M. H., Bergalet, J., Dejean, E., Joseph, N., Kruczynski, A., Soulier, J., Espinos, E., Meggetto, F., Cavaille, J., Delsol, G. and Lamant, L. (2011) MiR-29a downregulation in ALK-positive anaplastic large-cell lymphomas contributes to apoptosis blockade MCL-1 overexpression. Blood. 117, 6627-6637. DOI ScienceOn |
![]() |